Despite the fact that several states have granted authorization for medical marijuana usage, it stays categorised as a Plan one drug below federal benchmarks, lacking acknowledged medical programs and posing a big danger of abuse. Moreover, According to the American Society of Medical Oncology's 2017 pointers, there is insufficient evidence to